Why a Century-Old Vaccine Offers New Hope Against Pathogens
The B.C.G. tuberculosis vaccine may protect against Covid-19 and other infections by broadly bolstering the immune system. (Source: NYT Health)
Source: NYT Health - August 16, 2022 Category: Consumer Health News Authors: Roni Caryn Rabin Tags: your-feed-science Clinical Trials Diabetes Vaccination and Immunization Immune System Tuberculosis Coronavirus (2019-nCoV) Source Type: news

FDA accepts supplemental Biologics License Application for Roche ’s Polivy combination for people with previously untreated diffuse large B-cell lymphoma
First new treatment regimen in more than 20 years to significantly improve outcomes in people with this fast-growing type of lymphomaApplication is based on pivotal data from the phase III POLARIX study showing Polivy plus R-CHP significantly reduced therisk of disease progression, relapse or death with comparable safety versus the standard of care, R-CHOPVarious combination studies with Polivy and the company ' s CD20xCD3 bispecifics in diffuse large B-cell lymphoma are ongoingBasel, 16 August 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has accepted the compan...
Source: Roche Investor Update - August 16, 2022 Category: Pharmaceuticals Source Type: news

FDA accepts supplemental Biologics License Application for Roche ’s Polivy combination for people with previously untreated diffuse large B-cell lymphoma
First new treatment regimen in more than 20 years to significantly improve outcomes in people with this fast-growing type of lymphomaApplication is based on pivotal data from the phase III POLARIX study showing Polivy plus R-CHP significantly reduced therisk of disease progression, relapse or death with comparable safety versus the standard of care, R-CHOPVarious combination studies with Polivy and the company ' s CD20xCD3 bispecifics in diffuse large B-cell lymphoma are ongoingBasel, 16 August 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has accepted the compan...
Source: Roche Media News - August 16, 2022 Category: Pharmaceuticals Source Type: news

U.K. first to approve booster targeting coronavirus and omicron variant
The coronavirus shots were also effective against the omicron subvariants BA.4 and BA.5 in clinical trials, U.K. health authorities said. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - August 16, 2022 Category: Consumer Health News Authors: Andrew Jeong Source Type: news

Waltham biotech Checkpoint Therapeutics stops cancer study due to Ukraine war
A Waltham biotech is stopping a late-stage clinical trial of a cancer drug because of the ongoing war in Ukraine. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - August 15, 2022 Category: American Health Authors: Rowan Walrath Source Type: news

U.K. Approves Covid Booster Vaccine That Targets Two Variants
Britain is the first country to approve the Moderna-made vaccine, which generated a strong immune response against both the original virus and the Omicron variant. (Source: NYT Health)
Source: NYT Health - August 15, 2022 Category: Consumer Health News Authors: Jenny Gross Tags: Coronavirus (2019-nCoV) Coronavirus Omicron Variant Vaccination and Immunization Clinical Trials Research Medicines and Healthcare Products Regulatory Agency (Great Britain) Moderna Inc Source Type: news

Retrospective identification of infection in the emergency department: A significant challenge in sepsis clinical trials
Conclusions: Retrospective identification of infection poses a significant challenge in sepsis clinical trials. Using modified definitions of infection provides a standardized, less time consuming, and equally effective means of identifying infection compared to having multiple physicians adjudicate a patient ' s chart. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - August 15, 2022 Category: Consumer Health News Source Type: news

Walgreens Launches Clinical Trial Business with Goal of Leveraging Consumer Data, Technology, and Nationwide Reach to Increase Racial and Ethnic Diversity in Drug Research
By partnering with drug manufacturers to connect customers with clinical trials, the retail pharmacy chain believes this new venture will be the company’s ‘next growth engine’ Walgreens is launching a business to connect customers with clinical drug trials, a venture that adds another offering to the retail pharmacy giants’ growing menu of healthcare services. This […] The post Walgreens Launches Clinical Trial Business with Goal of Leveraging Consumer Data, Technology, and Nationwide Reach to Increase Racial and Ethnic Diversity in Drug Research appeared first on Dark Daily. (Source: Dark Daily)
Source: Dark Daily - August 15, 2022 Category: Laboratory Medicine Authors: Jillia Schlingman Tags: Laboratory Instruments & Laboratory Equipment Laboratory Management and Operations Laboratory News Laboratory Pathology Laboratory Resources Laboratory Testing anatomic pathology clinical laboratory CVS Dark Daily dark intelligence gro Source Type: news

Reduction of risk factors for ACL re-injuries using an innovative biofeedback approach: a phase I randomized clinical trial - Peebles AT, Miller TK, Savla J, Ollendick T, Messier SP, Queen RM.
OBJECTIVES: Determine the safety and initial efficacy of a novel biofeedback intervention to improve landing mechanics in patients following anterior cruciate ligament reconstruction (ACLR). METHODS: Forty patients post-ACLR (age: 16.9  ± 2.0 yea... (Source: SafetyLit)
Source: SafetyLit - August 15, 2022 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Submitted data for approval of intranasal vaccine to drug regulator: Bharat Biotech
According to the vaccine maker, it conducted two separate and simultaneous clinical trials to evaluate its intranasal vaccine (BBV154) as a primary dose (2-dose) schedule, and a heterologous booster dose for subjects who have previously received 2 doses of the two commonly administered covid vaccines in India including Covishield and Covaxin. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 15, 2022 Category: Pharmaceuticals Source Type: news

Bharat Biotech seeks nod for intranasal Covid vaccine
According to the vaccine maker, it conducted two separate and simultaneous clinical trials to evaluate its intranasal vaccine (BBV154) as a primary dose (2-dose) schedule, and a heterologous booster dose for subjects who have previously received 2 doses of the two commonly administered covid vaccines in India including Covishield and Covaxin. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 15, 2022 Category: Pharmaceuticals Source Type: news

Panel tackles woes of enrolling patients in Alzheimer's trials
People who want to participate in clinical trials for Alzheimer's disease fac...Read more on AuntMinnie.comRelated Reading: PET imaging to be used in Alzheimer's clinical trials PET shows amyloid beta + tau biomarkers = Alzheimer's disease CMS rethinks limit on PET scans for Alzheimer’s disease patients FDA grants approval for diagnostic test for Alzheimer's plaques PET with blood test promising in Alzheimer's disease clinical trials (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 12, 2022 Category: Radiology Source Type: news

Evidence Builds for Catheter Ablation for AF and Heart Failure Evidence Builds for Catheter Ablation for AF and Heart Failure
This article summarizes recent clinical trials which provide a growing body of evidence on the benefits of catheter ablation in the management of AF in patients with concomitant heart failure.Circulation (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - August 12, 2022 Category: Radiology Tags: Cardiology Journal Article Source Type: news

Adolescent suicide risk screening: a secondary analysis of the SHIELD randomized clinical trial - Sekhar DL, Batra E, Schaefer EW, Walker-Harding LR, Pattison KL, Molinari A, Rosen P, Kraschnewski JL, Waxmonsky JG.
OBJECTIVE: To evaluate the effectiveness of adolescent suicide risk screening to increase initiation of mental health services via a secondary analysis using data from the SHIELD randomized clinical trial, which evaluated school-based screening for major d... (Source: SafetyLit)
Source: SafetyLit - August 11, 2022 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Newest Dana-Farber Brigham Cancer Center opens in Foxborough
The facility will offer medical oncology and hematology care, blood transfusions, clinical trials and pharmacy. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - August 11, 2022 Category: Health Management Authors: Cassie McGrath Source Type: news